Contract 75A50122C00046
Abbott Laboratories · Department Of Health And Human Services · July 24, 2025
Abbott Laboratories was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on July 24, 2025 for $39.91 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in North Chicago, IL. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 19, 2026. If all options are exercised, the contract could reach $83.71 million.
Contract details
- PIID
- 75A50122C00046
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- Place of performance
- North Chicago, IL
- First action
- July 24, 2025
- Latest action
- March 19, 2026
Description
EXERCISE CLIN 0004 OPTION PERIOD 1 AND REVISE THE POP TO 3/23/26-11/15/29. REVISE THE TASKS IN CLIN 0006 OF THE SOW.
Modification timeline
-
March 19, 2026Mod P00008 · Supplemental Agreement For Work Within Scope$65.47M
-
July 24, 2025Mod P00007 · Supplemental Agreement For Work Within ScopeEXERCISE CLIN 006 OPTION PERIOD 3, SUPPLEMENTAL FUNDING FOR CLIN 0003 AND ADMINISTRATIVE REVISIONS.$44.45M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50122C00046?
Contract 75A50122C00046 is a federal contract awarded to Abbott Laboratories by Department Of Health And Human Services on July 24, 2025 for $39.91 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75A50122C00046?
Abbott Laboratories won contract 75A50122C00046 from Department Of Health And Human Services.
How much is contract 75A50122C00046 worth?
Contract 75A50122C00046 has obligated $39.91 million to date, with a total potential value of $83.71 million if all options are exercised.